Escape of autocrine ligands into extracellular medium: Experimental test of theoretical model predictions

Biotechnology and Bioengineering

Volumn 57, Issue 5, 1998, Pages 571-582

  Oehrtman, G T ^a   Wiley, H S ^b   Lauffenburger, D A ^a  

^a Massachusetts Institute of Technology Cambridge   (United States)

^b UNIVERSITY OF UTAH HEALTH SCIENCES CENTER   (United States)

Author keywords

Autocrine; Cell density; Modeling; TGF

Indexed keywords

ANTIBODIES; CELLS; DENSITY (SPECIFIC GRAVITY); MATHEMATICAL MODELS;

AUTOCRINE; TRANSFORMING GROWTH FACTOR (TGF);

BIOSYNTHESIS;

EPIDERMAL GROWTH FACTOR RECEPTOR; RECEPTOR ANTIBODY; TRANSFORMING GROWTH FACTOR ALPHA;

ANIMAL CELL; ARTICLE; AUTOCRINE EFFECT; CELL DENSITY; L CELL; MATHEMATICAL MODEL; MOUSE; NONHUMAN; PROTEIN SYNTHESIS; RECEPTOR BLOCKING;

ANIMALS; ANTIBODIES, MONOCLONAL; CELL DIVISION; CELLS, CULTURED; EXTRACELLULAR MATRIX; FIBROBLASTS; HUMANS; MATHEMATICS; MICE; MODELS, BIOLOGICAL; PLASMIDS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECOMBINANT PROTEINS; TETRACYCLINE; TRANSFECTION; TRANSFORMING GROWTH FACTOR ALPHA;

EID: 0032485340     PISSN: 00063592     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0290(19980305)57:5<571::AID-BIT9>3.0.CO;2-D     Document Type: Article

References (45)

1. Alberts, B., Bray, D., Lewis, J., Raff, M., Roberts, K., Watson, J. D. 1994. Molecular biology of the cell. 3rd edition. Garland Press, New York.
2. Barnard, J. A., Graves-Deal, R., Pittelkow, M., DuBois, R., Cook, P., Ramsey, G., Bishop, P., Damstrup, L., Coffey, R. J. 1994. Auto- and cross-induction within the mammalian epidermal growth factor-related peptide family. J. Biol. Chem. 269: 22817-22822.
3. Berg, H. C. 1983. Random walks in biology. 2nd edition. Princeton University Press, Princeton, N.J. pp. 30-34.
4. Boonstra, J., Rijken, P., Humbel, B., Cremers, F., Verkleij, A., van Bergen en Henegouwen, P. 1995. The epidermal growth factor. Cell Biol. Int. 19:413-430.
5. Carpenter, G., Wahl, M. I. 1990. The epidermal growth factor family, pp. 69-171. In: M. B. Sporn and A. B. Roberts (eds.), Peptide growth factors and their receptors. 1st edition. Springer-Verlag, New York.
6. Carraway, K. L., Cerione, R. A. 1993. Inhibition of epidermal growth factor receptor aggregation by an antibody directed against the epidermal growth factor receptor extracellular domain. J. Biol. Chem. 268: 23860-23867.
7. Chen, W. S., Lazar, C. S., Lund, K. A., Welsh, J. B., Chang, C. P., Walton, G. M., Der, C. J., Wiley, H. S., Gill, G. N., Rosenfeld, M. G. 1989. Functional independence of the epidermal growth factor receptor from a domain required for ligand-induced internalization and calcium regulation. Cell 59: 33-43.
8. Claret, E., Renversez, J. -C., Zheng, X., Bonnefoix, T., Sotto, J.-J. 1992. Valid estimation of IL-2 secretion by PHA-stimulated T-cell clones absolutely requires the use of anti-CD25 monoclonal antibody to prevent IL-2 consumption. Immunol. Lett. 33: 179-186.
9. Cohen, S. 1962. Isolation of a mouse submaxillary gland protein accelerating incisor eruption and eyelid opening in the new-born animal. J. Biol. Chem. 237: 1555-1562.
10. DeLarco, J. E., Todaro, G. J. 1978. Growth factors from murine sarcoma virus-transformed cells. Proc. Natl. Acad. Sci. U.S.A. 75: 4001-4005.
11. Dempsey, P. J., Coffey, R. J. 1994. Basolateral targeting and efficient consumption of transforming growth factor-α when expressed in Madin-Darby canine kidney cells. J. Biol. Chem. 269: 16878-16889.
12. Derynck, R., Roberts, A.B., Winkler, M.E., Chen, E.Y., Goeddel, D.V. 1984. Human transforming growth factor-α: Precursor structure and expression in E. Coli. Cell 38: 287-297.
13. Derynck, R. 1992. The physiology of transforming growth factor-α. Adv. Cancer Res. 58: 27-52.
14. Earp, H. S., Austin, K. S., Blaisdell, J., Rubin, R. A., Nelson, K. G., Lee, L. W., Grisham, J. W. 1986. EGF stimulates EGF receptor synthesis. J. Biol. Chem. 261: 4777-4780.
15. Filmus, J., Trent, J. M., Pollak, M. N., Buick, R. N. 1987. Epidermal growth factor receptor gene-amplified MDA-468 breast cancer cell line and its nonamplified variants. Mol. Cell. Biol. 7: 251-257.
16. Fontana, J. A., Nervi, C., Shao, Z., Jetten, A. M. 1992. Retinoid antagonism of estrogen-responsive transforming growth factor α and pS2 gene expression in breast carcinoma cells. Cancer Res. 52: 3938-3945.
17. Forsten, K. E., Lauffenburger, D. A. 1992a. Autocrine ligand binding to cell receptors: Mathematical analysis of competition by solution 'decoys'. Biophys. J. 61: 518-529.
18. Forsten, K. E., Lauffenburger, D. A. 1992b. Interrupting autocrine ligandreceptor binding: Comparison between receptor blockers and ligand decoys. Biophys. J. 63: 857-861.
19. Forsten, K. E., Lauffenburger, D. A. 1994. The role of low-affinity interleukin-2 receptors in autocrine ligand binding: Alternative mechanisms for enhanced binding effect. Mol. Immunol. 31: 739-751.
20. French, A. R., Sudlow, G. P., Wiley, H. S., Lauffenburger, D. A. 1994. Postendocytic trafficking of EGF-receptor complexes is mediated through saturable and specific endosomal interactions. J. Biol. Chem. 269: 15749-15755.
21. Gill, G. N., Bertics, P. J., Santon, J. B. 1987. Epidermal growth factor and its receptor. Mol. Cell. Endocrin. 51: 169-186.
22. Gong, Y., Ballejo, G., Murphy, L. C., Murphy, L. J. 1992. Differential effects of estrogen and anti-estrogen on transforming growth factor gene expression in endometrial adenocarcinoma cells. Cancer Res. 52: 1704-1709.
23. Gossen, M., Bujard, H. 1992. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc. Natl. Acad. Sci. U.S.A. 89: 5547-5551.
24. Hamburger, A. W., Pinnamaneni, G. 1992. Interferon-induced enhancement of transforming growth factor-α expression in a human breast cancer cell line. Proc. Soc. Exp. Biol. Med. 202: 64-68.
25. Knauer, D. J., Wiley, H. S., Cunningham, D.D. 1984. Relationship between epidermal growth factor receptor occupancy and mitogenic response. J. Biol. Chem. 259: 5623-5631.
26. Kriegler, M. 1990. DNA transfer, pp. 96-98. 3rd edition. In: M. Kriegler, (ed.), Gene transfer and expression. W. H. Freeman and Company, New York.
27. Kumar, V., Cotran, R. S., Robbins, S. L. 1992. Basic Pathology, 5th edition. W. B. Saunders, Philadelphia.
28. Lin, C. R., Chen, W. S., Lazar, C. S., Carpenter, C. D., Gill, G. N., Evans, R. M., Rosenfeld, M. G. 1986. Protein kinase C phosphorylation at Thr 654 of the unoccupied EGF receptor and EGF binding regulate functional receptor loss in independent mechanisms. Cell 44: 839-848.
29. Lund, K. A., Opresko, L. K., Starbuck, C., Walsh, B. J., Wiley, H. S., 1990. Quantitative analysis of the endocytic system involved in hormone-induced receptor internalization. J. Biol. Chem. 265: 15713-15723.
30. Massague, J., Pandiella, A. 1993. Membrane-anchored growth factors. Annu. Rev. Biochem. 62: 515-541.
31. Mendelsohn, J., Masui, H., Goldenberg, A. 1987. Anti-epidermal growth factor receptor monoclonal antibodies may inhibit A431 tumor cell proliferation by blocking an autocrine pathway. Trans. Assoc. Am. Physicians. 100: 173-178.
32. Modjtahedi, H., Eccles, S. A., Box, G., Styles, J., Dean, C. J. 1993. Antitumor activity of combinations of antibodies directed against different epitopes on the extracellular domain of the human EGF receptor. Cell Biophys. 22: 129-146.
33. Modjtahedi, H., Styles, J., Dean, C. 1993. The growth response of human tumor cell lines expressing the EGF receptor to treatment with EGF and/or Mabs that block ligand binding. Int. J. Oncol. 3: 237-243.
34. Oehrtman, G. T., Walker, L. L., Wiley, H. S., Lauffenburger, D. A. 1997. Methods for quantitative assessment of autocrine cell loops. In: M. Yarmush and J. Morgan (eds.), Methods in tissue engineering. Humana Press, Totowa, NJ (in press).
35. Opresko, L. K., Chang, C. P., Will, B. H., Burke, P. M., Gill, G. N., Wiley, H. S., 1995. Endocytosis and lysosomal targeting of epidermal growth factor receptors are mediated by distinct sequences independent of the tyrosine kinase domain. J. Biol. Chem. 270: 4325-4333.
36. Reiss, M., Stash, E. B., Vellucci, V. F., Zhou, Z. 1991. Activation of the autocrine transforming growth factor α pathway in human squamous carcinoma cells. Cancer Res. 51: 6254-6262.
37. Rodeck, U., Williams, N., Murthy, U., Herlyn, M. 1990. Monoclonal antibody 425 inhibits growth stimulation of carcinoma cells by exogenous EGF and tumor-derived EGF/TGFα. J. Cell. Biochem. 44: 69-79.
38. Sporn, M. B., Roberts, A. B. 1990. The multi-functional nature of peptide growth factors, pp. 3-15. In: Peptide growth factors and their receptors I, 1st edition. M. B. Sporn and A. B. Roberts, (eds.), Springer-Verlag, New York.
39. Sporn, M. B., Roberts, A. B. 1993. Autocrine secretion - 10 years later. Ann. Internal Med. 117: 408-414.
40. Starbuck, C., Wiley, H. S., Lauffenburger, D. A. 1990. Epidermal growth factor binding and trafficking dynamics in fibroblasts: Relationship to cell proliferation. Chem. Eng. Sci. 45: 2367-2373.
41. Van der Vijver, M. J., Kumar, R., Mendelsohn, J. 1991. Ligand-induced activation of A431 cell epidermal growth factor receptors occurs primarily by an autocrine pathway that acts upon receptors on the surface rather than intracellularly. J. Biol. Chem. 266: 7503-7508.
42. Wigler, M., Pellicer, A., Silverstein, S., Axel, R., Urlaub, G., Chasin, L. 1979. DNA-mediated transfer of the adenine phosphoribosyltransferase locus into mammalian cells. Proc. Natl. Acad. Sci. U.S.A. 76: 1373-1376.
43. Will, B. H., Lauffenburger, D. A., Wiley, H. S. 1995. Studies on engineered autocrine systems: requirements for ligand release from cells producing an artificial growth factor. Tissue Eng. 1: 83-96.
44. Yamada, Y., Serrero, G. 1988. Autocrine growth factor induced by the insulin-related factor in the insulin-dependent teratoma cell line 1246-3A. Proc. Natl. Acad. Sci. U.S.A. 85: 5936-5940.
45. Zorbas, M. A., Yeoman, L. C. 1993. Growth control in a human colon carcinoma cell line mediated by cell-associated TGFα. Exp. Cell. Res. 206: 49-57.